BioCatalyst

Upadacitinib, Adalimumab, Upadacitinib Matching Placebo, Adalimumab Matching Placebo — catalyst calendar

1 verified catalyst event(s) referencing Upadacitinib, Adalimumab, Upadacitinib Matching Placebo, Adalimumab Matching Placebo, each linked to its official source. Verified as of 2026-06-22.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-07 (month)
in 9d
ESTIMATED
 READOUT
Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitin
Phase 3 · Rheumatoid Arthritis
 ABBV AbbVie Inc. Upadacitinib, Adalimumab, Upadacitinib M ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.